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Abstract: Infective endocarditis (IE) is a serious, life-threatening disease with highly 
variable clinical signs, making its diagnostic a real challenge. A diagnosis is readily made 
if blood cultures are positive, but in 2.5 to 31% of all infective endocarditis cases, routine 
blood cultures are negative. In such situations, alternative diagnostic approaches are 
necessary.  Coxiella burnetii and Bartonella spp. are the etiological agents of blood   
culture-negative endocarditis (BCNE) most frequently identified by serology. The purpose 
of this study is to investigate the usefulness of molecular assays, as complementary 
methods to the conventional serologic methods for the rapid confirmatory diagnostic of  
Q fever endocarditis in patients with BCNE. Currently, detection of C. burnetii by culture 
or an antiphase I IgG antibody titers >800 represents a major Duke criterion for defining  
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IE, while a titers of >800 for IgG antibodies to either B. henselae or B. quintana is used for 
the diagnosis of endocarditis due to Bartonella spp. We used indirect immunofluorescence 
assays for the detection of IgG titers for C. burnetii,  B. henselae and B. quintana in   
57 serum samples from patients with clinical suspicion of IE. Thirty three samples 
originated from BCNE patients, whereas 24 were tested before obtaining the blood cultures 
results, which finally were positive. The results of serologic testing showed that nine out of 
33 BCNE cases exhibited antiphase I C. burnetii IgG antibody titer >800, whereas none 
has IgG for B. henselae or B. quintana. Subsequently, we used nested-PCR assay for the 
amplification of C. burnetii DNA in the nine positive serum samples, and we obtained 
positive PCR results for all analyzed cases. Afterwards we used the DNA sequencing of 
amplicons for the repetitive element associated to htpAB gene to confirm the results of 
nested-PCR. The results of sequencing allowed us to confirm that C. burnetii is the 
causative microorganism responsible for BCNE. In conclusion, the nested PCR 
amplification followed by direct sequencing is a reliable and accurate method when applied 
to serum samples, and it may be used as an additional test to the serological methods for 
the confirmatory diagnosis of BCNE cases determined by C. burnetii.  
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1. Introduction  
Infective endocarditis is a serious, life-threatening disease with highly variable clinical signs that 
are making the condition a diagnostic challenge. A diagnosis is readily made if blood cultures are 
positive, but in 2.5 to 31% of all infective endocarditis cases, routine blood cultures are negative [1–3]. 
This variation in incidence could be explained by several factors, including: (i) differences in the 
diagnostic criteria used; (ii) specific epidemiological factors, as for fastidious zoonotic agents;   
(iii) variations in the early use of antibiotics before the blood sampling; (iv) differences in sampling 
strategies; or (v) involvement of unknown pathogens [4,5]. 
Blood culture negative endocarditis (BCNE) was recognized by Osler at the beginning of last 
century [6,7]. Recently, many publications in European countries have demonstrated a significant 
involvement of Coxiella burnetti, Bartonella henselae, and B. quintana in patients with BCNE [8,9].  
C. burnetii is one of the most encountered fastidious agents in BCNE. Q fever is characterized by its 
clinical polymorphism and the presentation of the disease is variable, with both acute and chronic 
manifestations [10,11]. Following acute infection, 1 to 5% of patients progress to chronic infection, 
which can develop after months to several years after acute Q fever infection, the longest interval 
being 20 years after infection [12,13].  
Endocarditis is the main form of chronic Q fever (78% of all chronic Q fever cases) [14]. The most 
exposed persons are patients with preexistent valvular disease or vascular defects, especially aortic 
aneurysm and aortic stents and prostheses, immunocompromised patients, and pregnant women [15–18]. 
The estimated risk of transformation from acute infection to Q fever endocarditis in patients with 
preexisting valvulopathy is approximately 40% [17]. Because symptoms of Q fever endocarditis are Int. J. Mol. Sci. 2011, 12                 
 
 
9506
protean and not specific, diagnosis is often delayed, only after significant valvular damage has 
occurred, resulting in an increasing mortality rate. Some authors proposed that all patients with acute  
Q fever be investigated by a transthoracic echocardiography [19].  
The diagnosis of Q fever endocarditis requires both clinical endocarditis and isolation or serologic 
evidence of C burnetii. Because Q fever endocarditis is a chronic illness, a single serum specimen is 
sufficient for diagnosis. A phase I IgG titers of 800 or greater is one of the major modified Duke 
criteria [20]. Previously studies showed that PCR with serum samples may be helpful in establishing 
an early diagnosis of chronic Q fever [21]. 
Currently there is no data concerning the incidence of Q fever endocarditis cases among Romanian 
population. The first Q fever cases in Romania were registered in 1947 in Constanta County [22]. The 
most recent data about Q fever in Romania were represented by urban sporadic cases reported in the 
period 1981–1987 [23].  
2. Results and Discussion  
2.1. Case Definitions 
Patients were considered to have definite blood culture-negative endocarditis if the results of 
standard blood cultures were negative, and if clinical and echocardiographic findings met the Duke 
criteria for infective endocarditis. All serum samples tested by serological methods for detection of 
IgG to C. burnetii, B. quintana and B. henselae originated from patients with clinical suspicion of 
BCNE. According to the modified Duke criteria a single positive blood culture for Coxiella burnetii or 
antiphase I IgG antibody titers >800 represents a major criterion for definite infective endocarditis [24]. 
The results of serological testing showed that 9 out of 33 serum samples exhibited antiphase I   
C. burnetii IgG antibody titers >800, while none of samples has IgG for B. henselae or B. quintana. 
The modified Duke criteria used for definite infective endocarditis (IE) diagnosis of analyzed patients 
with clinical suspicions of BCNE are presented in Table 1. 
Table 1. The modified Duke criteria used for defining infective endocarditis (IE) diagnosis 
applied to the nine patients. 
Case 
Age 
(years)/sex 
Major criteria 
Minor 
criteria 
Antiphase I 
C. burnetii IgG 
antibody titer 
>800 
Evidence of endocardial 
involvement—
Echocardiography 
positive for IE-vegetation 
Evidence of 
endocardial 
involvement—New 
valvular regurgitation 
1 51/M  Present  MV  MV;  AV  Fever   38 °C 
2 62/F  Present  -  MV  Fever   38 °C 
3 58/M  Present  AV  AV  Fever   38 °C 
4 64/M  Present  MV  AV;  MV  Fever   38 °C 
5  60/M  Present  AV; MV  AV; MV  Fever  38 °C 
6 57/M  Present  -  -  Fever   38 °C 
7 70/F  Present  MV  AV;  MV  Fever   38 °C 
8 64/M  Present  AV  AV  Fever   38 °C 
9 60/M  Present  MV  AV;  MV  Fever   38 °C 
Note: MV—mitral valve; AV—aortic valve. Int. J. Mol. Sci. 2011, 12                 
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Diagnosis of IE is definite if there are 2 major criteria or 1 major and 3 minor criteria or 5 minor 
criteria [25,26]. Eight out of nine investigated cases fulfilled 2 major criteria (antiphase I C. burnetii 
IgG antibody titer >800 and when there is a vegetation or a new valvular regurgitation) for defining IE, 
while the remaining case fulfilled one major criterion (antiphase I C. burnetii IgG antibody titers >800) 
and one minor criterion (fever  38 °C), being classified as a possible case. 
It is well-known that endocarditis is the most common presentation of chronic Q fever. Initially 
thought to be a rare disorder, later it has been estimated to account for up to 5% of all endocarditis 
cases worldwide [27]. It occurs almost exclusively in patients who have pre-existing valvular disease 
or who are immunocompromised. Unlike typical cases of endocarditis, the clinical presentation of 
endocarditis from chronic Q fever is often nonspecific and lacks many of the typical features of 
subacute, bacterial endocarditis, such as usual clinical and echocardiographic features common to 
typical cases of endocarditis [28]. Thus, the diagnosis is often significantly delayed or even missed, 
resulting in significant morbidity and mortality. Despite increasing awareness, recent studies show a 
mean delay of seven months from symptom onset to diagnosis [29,30]. Without prompt recognition and 
adequate antimicrobial therapy, the course of Q fever endocarditis is severe and potentially fatal [30].  
The diagnosis of Q fever endocarditis is hampered by the inability to culture C. burnetii using 
routine media. As a strict obligate intracellular bacterium, it can only be cultured in living cell lines, or 
embryonated chicken eggs, but the cultures cannot be easily performed in most laboratories, and the 
technique is restricted to biosafety level 3 laboratories. Thus, the diagnosis of chronic Q fever, 
therefore, relies on serological testing, being characterized by increased titres against the phase I antigen.  
2.2. PCR and Sequencing Results 
Detection of C. burnetii DNA by PCR is an important diagnostic method that could be used on 
different types of clinical specimens (blood, serum, infected heart valves) [31]. During the last years, 
several PCR based diagnostic assays have been developed to detect C. burnetii DNA in cell cultures 
and clinical samples. These assays used conventional PCR [32], nested PCR [33–36] or real-time PCR 
conditions with LightCycler [37,38], SYBR Green [39] or TaqMan chemistry. The target sequences of 
the assays originated from single chromosomal genes like com1, on plasmids (QpH1, QpRS) or within 
the transposase gene of insertion element IS1111 that is present in 20 copies in the genome of the  
C. burnetii Nine Mile RSA493 strain [40]. Due to the multicopy number of the IS1111 element, the 
corresponding PCR is very sensitive.  
The results of PCR assays performed on DNA from serum samples positive for antiphase I   
C. burnetii IgG showed that nested-PCR assay permitted the amplification of C. burnetii DNA. Thus, 
nested-PCR led to obtaining the amplification products of the repetitive element IS1111a associated to 
htpAB transposase gene in the second round of amplification for all analyzed DNAs (Figure 1).  Int. J. Mol. Sci. 2011, 12                 
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Figure 1. Gel electrophoresis of amplification products from the second round of repetitive 
element associated to htpAB gene in analyzed DNA samples of Q fever endocarditis cases. 
Line 1—Gene Ruler 100 bp Plus DNA Ladder (Fermentas); 2–5 and 7–8—DNA samples 
from Q fever endocarditis cases, 6—negative serum for C. burnetii; 9—negative control 
(pure water). 
 
3. Experimental Section  
3.1. Patients 
In this study we analyzed the role of C. burnetii as causative agent of blood culture negative infective 
endocarditis among patients with clinical diagnostic of infective endocarditis. The blood-cultures were 
performed for 102 patients hospitalized in three Institutes for Cardiovascular Diseases from Bucharest, 
Timisoara and Targu-Mures, and in Clinical Hospital for Infectious Diseases from Cluj. For each patient, 
a standardized questionnaire was filled by the physician in charge and logged into a database. The 
information filled in the questionnaire were consisted of: known preexisting valvular defect, type of 
valve involved (native/bioprosthetic/mechanical valve, and its position: aortic, mitral, tricuspid, 
pulmonary); previous antibiotic therapy; clinical symptoms; and laboratory results. Patients were 
considered to have possible or definite endocarditis according to the modified Duke criteria.  
3.2. Indirect Immunofluorescence Assays 
57 serum samples were tested by indirect immunofluorescence assay (IFA) for detection of IgG 
antibodies to C. burnetii, B. henselae and B. quintana. From these samples 33 originated from patients 
with BCNE, and the rest of samples were tested before obtaining the blood cultures results, which 
finally were positive. We used IFA kits (Vircell, Spain) for detection of IgG antiphase I and antiphase 
II C. burnetii, and for IgG to B. quintana and IgG to B. henseale. The presence of IgG titers >800  
to  C. burnetii or B. quintana or B. henselae were considered positive for endocarditis diagnosis. 
Furthermore, we analyzed the positive serum samples for C. burnetii with antiphase I IgG antibody 
titers >800 using molecular methods for the confirmation of serological results.  
3.3. Molecular Methods 
3.3.1. DNA Extraction 
The serum samples from nine patients with antiphase I C. burnetii IgG antibody titer >800, were 
used for DNA extraction. Total genomic DNA was extracted from 200 microliters of serum using the Int. J. Mol. Sci. 2011, 12                 
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QIAamp blood kit (Qiagen, Hilden, Germany) according to the manufacturer instructions. DNA was 
resuspended in fifty microliters of elution buffer. Genomic DNAs were stored at 4 °C until their use as 
templates in PCR assays and subsequently at −20 °C. DNA samples have been handled carefully to 
avoid the risk of cross-contamination. DNA extraction, mix preparation, and PCR were performed in 
different rooms to prevent PCR carryover contamination. No positive control was used to prevent 
lateral contamination (i.e., contamination caused by PCR products amplified in other tubes in the same 
assay). DNA extracted from serum specimens of blood donors was used every 4 specimens as a 
negative control.  
3.3.2. PCR Assay 
We used a nested-PCR assay for detection of the repetitive element IS1111 associated to htpAB 
transposase gene (GenBank accession number M80806). This repetitive element is present in multiple 
copies in the genome of C. burnetii strains (e.g., there are 20 copies of this element in the C. burnetii 
Nine Mile I genome), which increase the detection sensitivity of this pathogen in serum samples [21]. 
In the first round of amplification we used IS111F1 and IS111R1 primers, which were designed to 
amplify a 485-bp fragment of the repetitive element IS1111, while the second round of amplification 
was performed using the IS111F2 and IS111R2 primers, which amplify an internal 260-bp fragment 
from the same target [27]. The sequence of specific primers used in nested-PCR reactions, and the 
molecular size of the amplicons are presented in Table 2.  
Table 2. The primer sequences used in nested-PCR assay for the repetitive element 
IS1111a of htpAB transposase. 
The gene  Primer  Nucleotide sequence  Amplicon size (bp)
IS1111 
IS111F1 
IS111R1 
5′- TACTGGGTGTTGATATTGC-3′
5′- CCGTTTCATCCGCGGTG-3′ 
485 
IS111F2 
IS111R2 
5′- GTAAAGTGATCTACACGA-3′ 
5′- TTAACAGCGCTTGAACGT-3′ 
260 
In the nested-PCR assay, each gene fragment amplified separately on 2700 Applied Biosystems 
instrument using necessary components provided by Promega. The components used in each type of 
PCR reaction are described in Table 3. The parameters for the amplification cycles used in each PCR 
experiment are presented in Table 4. PCR products from nested-PCR assay were separated in a 1.5% 
agarose gel for 1 h at 100 V, stained with ethidium bromide and detected by UV transillumination. 
Table 3. The components used in nested-PCR reactions. 
The components used in nested-PCR 
Primers 
conc. 
MgCl2 
conc. 
dNTP mix 
conc. 
DNA TaqPol 
conc. 
TaqPol 
buffer conc. 
DNA 
conc. 
Volume/ 
reaction 
0.3 µM  2.5 mM  0.2 mM  0.025 U/µL  1×  50 ng/µL  50 µL 
 Int. J. Mol. Sci. 2011, 12                 
 
 
9510
Table 4. The conditions used for the amplification of repetitive element IS1111 of htpAB 
transposase gene. 
Gene 
The amplification program for nested PCR assay 
Initial 
denaturation 
No. of 
cycles 
Denaturation 
in each cycle  Annealing  Primers 
extension 
Final 
extension 
IS1111—first round 
94 °C, 5 min  35  94 °C, 1 min 
52 °C, 1 min 
72 °C, 1 min  72 °C, 5 min  IS1111—second 
round  48 °C, 1 min 
3.3.3. Sequencing of PCR Products and Sequence Analysis 
The sequencing of the amplicons from nested-PCR has been used to confirm the PCR results. The 
amplicons from the second round of nested-PCR were sequenced in both directions using the BigDye 
V3.1 kit as described by the manufacturer. Sequencing products have been resolved using an ABI 3100 
automated  Avant Genetic Analyzer (Applied Biosystems). Sequence analysis was performed with 
BioEdit program, which permitted obtaining of the consensus sequences that were compared with 
similar sequences from BLAST. The sequences obtained showed a sequence similarity of 100% with 
that of the GenBank prototype strain sequence. Thus, sequencing of the amplicons from the second 
round of PCR reaction has permitted to confirm that amplification products belong to C. burnetii. 
These two molecular tests were used together for the first time to investigate the BCNE cases with  
C. burnetii in Romania.  
4. Conclusions 
We propose that all patients with clinical suspicion of IE be tested serologically for evidence of 
infection with other agents such as C. burnetii in parallel with performing blood cultures.  
This is the first report in this country for using the molecular methods to confirm Q fever endocarditis 
cases on the serum samples from eight confirmed cases and from one possible case of Q fever 
endocarditis tested by nested-PCR, based on repetitive element IS1111a of the transposase gene. This 
assay exhibited high sensitivity and specificity and led us to obtain specific amplification products, 
which were subsequently confirmed by direct sequencing to belong to C. burnetii, confirming previous 
studies showing that this nested-PCR assay presents a specificity of 100% and a sensitivity of one  
C. burnetii DNA copy [27]. In conclusion, our results have demonstrated that nested-PCR 
amplification, followed by direct sequencing, is a reliable and accurate method when applied to serum 
samples and can be used as a supplementary diagnosis tool for BCNE cases.  
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